Pear Therapeutics Announces Publication of Economic Analysis Assessing the Cost-Effectiveness of reSET-O® in Treating Opioid Use Disorder (OUD)
reSET-O® is the first and only FDA-authorized Prescription Digital Therapeutic (PDT) for patients with opioid